fenspiride has been researched along with arachidonic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachelet, M; De Castro, CM; Dumarey, CH; Nahori, MA; Vargaftig, BB | 1 |
| Broué-Chabbert, A; Girard, V; Gossart, S; Pinelli, E; Pipy, B; Quartulli, F | 1 |
| Jankowski, R | 1 |
3 other study(ies) available for fenspiride and arachidonic acid
| Article | Year |
|---|---|
Fenspiride: an anti-inflammatory drug with potential benefits in the treatment of endotoxemia.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Cyclic AMP; Endotoxins; Guinea Pigs; Lipopolysaccharides; Macrophages, Alveolar; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases A; Phospholipases A2; Spiro Compounds; Tumor Necrosis Factor-alpha | 1995 |
Fenspiride inhibits histamine-induced responses in a lung epithelial cell line.
Topics: Arachidonic Acid; Bronchodilator Agents; Calcium; Cell Line; Cimetidine; Cyclooxygenase Inhibitors; Diphenhydramine; Epithelial Cells; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Lipoxygenase Inhibitors; Lung; Spiro Compounds | 1998 |
[ENT inflammation and importance of fenspiride].
Topics: Animals; Arachidonic Acid; Cell Movement; Chronic Disease; Cyclic AMP; Histamine H1 Antagonists; Humans; Inflammation; Neutrophils; Otorhinolaryngologic Diseases; Receptors, Adrenergic, alpha; Spiro Compounds | 2002 |